Greek crisis creates medicine shortages

June 6, 2012 by Helene Colliopoulou

Greece's highly uncertain future has forced businesses into a quasi hand-to-mouth existence, with one of the most alarming effects a shortage of medicines, including for the seriously ill.

"Pharmaceutical companies are no longer interested in selling to Greece where hospitals and pharmacies are in debt," said Kostas Lourantos, head of the pharmacies' association in the Attica region that includes the capital Athens.

"This is the case with Roche, Bayer, and Sanofi" and other big pharma companies, he said. "Drug prices are also very low compared to other European countries."

He added that there are currently shortages of medicines such as antibiotics, antidepressants and insulin for diabetes sufferers.

Ahead of elections on June 17 that may result in Greece departing the eurozone, business as usual is already a thing of the past as firms in all sectors brace themselves for potential economic chaos.

"Everybody is just waiting for the new government. This political uncertainty is exacerbating an already bad , with loans down to zero," Eleftherios Kourtalis, head of the federation, told AFP.

For importers in particular the situation is drastic, with their suppliers abroad increasingly demanding that they be paid up-front while Greek firms can still pay in euros, instead of on credit.

Last week Euler Hermes, the world's number one trade credit insurer, said that it was no longer providing cover for firms exporting goods to Greece, following a similar move by Coface, owned by French bank Natixis.

"These decisions put a bomb under the foundations of the economy, rattling the basis for production and commerce," said Christina Sakellaridi, president of the Greek exporters' federation.

The result, she said, was a "reduction in imports of primary goods needed by Greek manufacturers."

Worst-hit is health care, a sector which is also grappling with problems of its own, most notably state EOPYY's problems in reimbursing pharmacies for medicines sold to consumers at a much-reduced rate.

"EOPYY owes us 750 million euros dating back to January 2012, adding to debts of 250 million euros from last year," said Lourantos from the pharmacies' association.

The government is trying to help, meanwhile, with the health ministry recently freeing up loans needed to buy emergency medication, while EOPYY last week paid off 200 million euros of its arrears.

Following several strikes, pharmacies recently began increasing the pressure by demanding that patients supposedly insured by EOPYY pay the full price for medicines.

"Many patients cannot pay," said Vassiliki Kalyva, the owner of a in central Athens.

Those with serious illnesses including cancer "are finding it hard to find their drugs because they are very expensive and neither hospitals nor pharmacies can afford to buy them."

Explore further: Google to settle drug probe for $500 million

Related Stories

Google to settle drug probe for $500 million

August 24, 2011
Google will pay $500 million to settle charges that it sold advertisements to Canada-based online pharmacies which marketed drugs to Americans in violation of US law, US justice officials announced Wednesday.

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.